Global OTC Anti-Infective Drug Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global OTC Anti-Infective Drug Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Anti-Infective Drug Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Antifungal
1.2.3 Antibacterial
1.2.4 Antiviral
1.2.5 Antiseptics
1.2.6 Other
1.3 Market by Application
1.3.1 Global OTC Anti-Infective Drug Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global OTC Anti-Infective Drug Market Size (2017-2028)
2.2 OTC Anti-Infective Drug Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global OTC Anti-Infective Drug Market Size by Region (2017-2022)
2.4 Global OTC Anti-Infective Drug Market Size Forecast by Region (2023-2028)
2.5 Global Top OTC Anti-Infective Drug Countries Ranking by Market Size
3 OTC Anti-Infective Drug Competitive by Company
3.1 Global OTC Anti-Infective Drug Revenue by Players
3.1.1 Global OTC Anti-Infective Drug Revenue by Players (2017-2022)
3.1.2 Global OTC Anti-Infective Drug Market Share by Players (2017-2022)
3.2 Global OTC Anti-Infective Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by OTC Anti-Infective Drug Revenue
3.4 Global OTC Anti-Infective Drug Market Concentration Ratio
3.4.1 Global OTC Anti-Infective Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Anti-Infective Drug Revenue in 2021
3.5 Global OTC Anti-Infective Drug Key Players Head office and Area Served
3.6 Key Players OTC Anti-Infective Drug Product Solution and Service
3.7 Date of Enter into OTC Anti-Infective Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global OTC Anti-Infective Drug Breakdown Data by Type
4.1 Global OTC Anti-Infective Drug Historic Revenue by Type (2017-2022)
4.2 Global OTC Anti-Infective Drug Forecasted Revenue by Type (2023-2028)
5 Global OTC Anti-Infective Drug Breakdown Data by Application
5.1 Global OTC Anti-Infective Drug Historic Market Size by Application (2017-2022)
5.2 Global OTC Anti-Infective Drug Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America OTC Anti-Infective Drug Revenue by Company (2020-2022)
6.2 North America OTC Anti-Infective Drug Revenue by Type (2017-2028)
6.3 North America OTC Anti-Infective Drug Revenue by Application (2017-2028)
6.4 North America OTC Anti-Infective Drug Revenue by Country (2017-2028)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe OTC Anti-Infective Drug Revenue by Company (2020-2022)
7.2 Europe OTC Anti-Infective Drug Revenue by Type (2017-2028)
7.3 Europe OTC Anti-Infective Drug Revenue by Application (2017-2028)
7.4 Europe OTC Anti-Infective Drug Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific OTC Anti-Infective Drug Revenue by Company (2020-2022)
8.2 Asia Pacific OTC Anti-Infective Drug Revenue by Type (2017-2028)
8.3 Asia Pacific OTC Anti-Infective Drug Revenue by Application (2017-2028)
8.4 Asia Pacific OTC Anti-Infective Drug Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America OTC Anti-Infective Drug Revenue by Company (2020-2022)
9.2 Latin America OTC Anti-Infective Drug Revenue by Type (2017-2028)
9.3 Latin America OTC Anti-Infective Drug Revenue by Application (2017-2028)
9.4 Latin America OTC Anti-Infective Drug Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa OTC Anti-Infective Drug Revenue by Company (2020-2022)
10.2 Middle East and Africa OTC Anti-Infective Drug Revenue by Type (2017-2028)
10.3 Middle East and Africa OTC Anti-Infective Drug Revenue by Application (2017-2028)
10.4 Middle East and Africa OTC Anti-Infective Drug Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer OTC Anti-Infective Drug Products and Services
11.1.4 Bayer OTC Anti-Infective Drug Revenue in OTC Anti-Infective Drug Business (2017-2022)
11.1.5 Bayer OTC Anti-Infective Drug SWOT Analysis
11.1.6 Bayer Recent Developments
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK OTC Anti-Infective Drug Products and Services
11.2.4 GSK OTC Anti-Infective Drug Revenue in OTC Anti-Infective Drug Business (2017-2022)
11.2.5 GSK OTC Anti-Infective Drug SWOT Analysis
11.2.6 GSK Recent Developments
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Teva Business Overview
11.3.3 Teva OTC Anti-Infective Drug Products and Services
11.3.4 Teva OTC Anti-Infective Drug Revenue in OTC Anti-Infective Drug Business (2017-2022)
11.3.5 Teva OTC Anti-Infective Drug SWOT Analysis
11.3.6 Teva Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson OTC Anti-Infective Drug Products and Services
11.4.4 Johnson & Johnson OTC Anti-Infective Drug Revenue in OTC Anti-Infective Drug Business (2017-2022)
11.4.5 Johnson & Johnson OTC Anti-Infective Drug SWOT Analysis
11.4.6 Johnson & Johnson Recent Developments
11.5 NOVARTIS
11.5.1 NOVARTIS Company Details
11.5.2 NOVARTIS Business Overview
11.5.3 NOVARTIS OTC Anti-Infective Drug Products and Services
11.5.4 NOVARTIS OTC Anti-Infective Drug Revenue in OTC Anti-Infective Drug Business (2017-2022)
11.5.5 NOVARTIS OTC Anti-Infective Drug SWOT Analysis
11.5.6 NOVARTIS Recent Developments
11.6 MYLAN
11.6.1 MYLAN Company Details
11.6.2 MYLAN Business Overview
11.6.3 MYLAN OTC Anti-Infective Drug Products and Services
11.6.4 MYLAN OTC Anti-Infective Drug Revenue in OTC Anti-Infective Drug Business (2017-2022)
11.6.5 MYLAN OTC Anti-Infective Drug SWOT Analysis
11.6.6 MYLAN Recent Developments
11.7 Sun Pharma
11.7.1 Sun Pharma Company Details
11.7.2 Sun Pharma Business Overview
11.7.3 Sun Pharma OTC Anti-Infective Drug Products and Services
11.7.4 Sun Pharma OTC Anti-Infective Drug Revenue in OTC Anti-Infective Drug Business (2017-2022)
11.7.5 Sun Pharma OTC Anti-Infective Drug SWOT Analysis
11.7.6 Sun Pharma Recent Developments
11.8 CR SANJIU
11.8.1 CR SANJIU Company Details
11.8.2 CR SANJIU Business Overview
11.8.3 CR SANJIU OTC Anti-Infective Drug Products and Services
11.8.4 CR SANJIU OTC Anti-Infective Drug Revenue in OTC Anti-Infective Drug Business (2017-2022)
11.8.5 CR SANJIU OTC Anti-Infective Drug SWOT Analysis
11.8.6 CR SANJIU Recent Developments
11.9 Cipla
11.9.1 Cipla Company Details
11.9.2 Cipla Business Overview
11.9.3 Cipla OTC Anti-Infective Drug Products and Services
11.9.4 Cipla OTC Anti-Infective Drug Revenue in OTC Anti-Infective Drug Business (2017-2022)
11.9.5 Cipla OTC Anti-Infective Drug SWOT Analysis
11.9.6 Cipla Recent Developments
11.10 Lingrui
11.10.1 Lingrui Company Details
11.10.2 Lingrui Business Overview
11.10.3 Lingrui OTC Anti-Infective Drug Products and Services
11.10.4 Lingrui OTC Anti-Infective Drug Revenue in OTC Anti-Infective Drug Business (2017-2022)
11.10.5 Lingrui OTC Anti-Infective Drug SWOT Analysis
11.10.6 Lingrui Recent Developments
12 OTC Anti-Infective Drug Market Dynamics
12.1 OTC Anti-Infective Drug Market Trends
12.2 OTC Anti-Infective Drug Market Drivers
12.3 OTC Anti-Infective Drug Market Challenges
12.4 OTC Anti-Infective Drug Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global OTC Anti-Infective Drug Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Antifungal
Table 3. Key Players of Antibacterial
Table 4. Key Players of Antiviral
Table 5. Key Players of Antiseptics
Table 6. Key Players of Other
Table 7. Global OTC Anti-Infective Drug Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global OTC Anti-Infective Drug Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 9. Global OTC Anti-Infective Drug Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global OTC Anti-Infective Drug Revenue Market Share by Region (2017-2022)
Table 11. Global OTC Anti-Infective Drug Revenue by Players (2017-2022) & (US$ Million)
Table 12. Global OTC Anti-Infective Drug Market Share by Players (2017-2022)
Table 13. Global Top OTC Anti-Infective Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Drug as of 2021)
Table 14. Ranking of Global Top OTC Anti-Infective Drug Companies by Revenue (US$ Million) in 2021
Table 15. Global 5 Largest Players Market Share by OTC Anti-Infective Drug Revenue (CR5 and HHI) & (2017-2022)
Table 16. Key Players Headquarters and Area Served
Table 17. Key Players OTC Anti-Infective Drug Product Solution and Service
Table 18. Date of Key Manufacturers Enter into OTC Anti-Infective Drug Market
Table 19. Mergers & Acquisitions, Expansion Plans
Table 20. Global OTC Anti-Infective Drug Market Size by Type (2017-2022) & (US$ Million)
Table 21. Global OTC Anti-Infective Drug Revenue Market Share by Type (2017-2022)
Table 22. Global OTC Anti-Infective Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 23. Global OTC Anti-Infective Drug Revenue Market Share by Type (2023-2028)
Table 24. Global OTC Anti-Infective Drug Market Size by Application (2017-2022) & (US$ Million)
Table 25. Global OTC Anti-Infective Drug Revenue Market Share by Application (2017-2022)
Table 26. Global OTC Anti-Infective Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 27. Global OTC Anti-Infective Drug Revenue Market Share by Application (2023-2028)
Table 28. North America OTC Anti-Infective Drug Revenue by Company (2020-2022) & (US$ Million)
Table 29. North America OTC Anti-Infective Drug Revenue by Type (2017-2022) & (US$ Million)
Table 30. North America OTC Anti-Infective Drug Revenue by Type (2023-2028) & (US$ Million)
Table 31. North America OTC Anti-Infective Drug Revenue by Application (2017-2022) & (US$ Million)
Table 32. North America OTC Anti-Infective Drug Revenue by Application (2023-2028) & (US$ Million)
Table 33. North America OTC Anti-Infective Drug Revenue by Country (2017-2022) & (US$ Million)
Table 34. North America OTC Anti-Infective Drug Revenue by Country (2023-2028) & (US$ Million)
Table 35. Europe OTC Anti-Infective Drug Revenue by Company (2020-2022) & (US$ Million)
Table 36. Europe OTC Anti-Infective Drug Revenue by Type (2017-2022) & (US$ Million)
Table 37. Europe OTC Anti-Infective Drug Revenue by Type (2023-2028) & (US$ Million)
Table 38. Europe OTC Anti-Infective Drug Revenue by Application (2017-2022) & (US$ Million)
Table 39. Europe OTC Anti-Infective Drug Revenue by Application (2023-2028) & (US$ Million)
Table 40. Europe OTC Anti-Infective Drug Revenue by Country (2017-2022) & (US$ Million)
Table 41. Europe OTC Anti-Infective Drug Revenue by Country (2023-2028) & (US$ Million)
Table 42. Asia Pacific OTC Anti-Infective Drug Revenue by Company (2020-2022) & (US$ Million)
Table 43. Asia Pacific OTC Anti-Infective Drug Revenue by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific OTC Anti-Infective Drug Revenue by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific OTC Anti-Infective Drug Revenue by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific OTC Anti-Infective Drug Revenue by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific OTC Anti-Infective Drug Revenue by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific OTC Anti-Infective Drug Revenue by Region (2023-2028) & (US$ Million)
Table 49. Latin America OTC Anti-Infective Drug Revenue by Company (2020-2022) & (US$ Million)
Table 50. Latin America OTC Anti-Infective Drug Revenue by Type (2017-2022) & (US$ Million)
Table 51. Latin America OTC Anti-Infective Drug Revenue by Type (2023-2028) & (US$ Million)
Table 52. Latin America OTC Anti-Infective Drug Revenue by Application (2017-2022) & (US$ Million)
Table 53. Latin America OTC Anti-Infective Drug Revenue by Application (2023-2028) & (US$ Million)
Table 54. Latin America OTC Anti-Infective Drug Revenue by Country (2017-2022) & (US$ Million)
Table 55. Latin America OTC Anti-Infective Drug Revenue by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa OTC Anti-Infective Drug Revenue by Company (2020-2022) & (US$ Million)
Table 57. Middle East and Africa OTC Anti-Infective Drug Revenue by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa OTC Anti-Infective Drug Revenue by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa OTC Anti-Infective Drug Revenue by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa OTC Anti-Infective Drug Revenue by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa OTC Anti-Infective Drug Revenue by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa OTC Anti-Infective Drug Revenue by Country (2023-2028) & (US$ Million)
Table 63. Bayer Company Details
Table 64. Bayer Business Overview
Table 65. Bayer OTC Anti-Infective Drug Product and Services
Table 66. Bayer OTC Anti-Infective Drug Revenue in OTC Anti-Infective Drug Business (2017-2022) & (US$ Million)
Table 67. Bayer OTC Anti-Infective Drug SWOT Analysis
Table 68. Bayer Recent Developments
Table 69. GSK Company Details
Table 70. GSK Business Overview
Table 71. GSK OTC Anti-Infective Drug Product and Services
Table 72. GSK OTC Anti-Infective Drug Revenue in OTC Anti-Infective Drug Business (2017-2022) & (US$ Million)
Table 73. GSK OTC Anti-Infective Drug SWOT Analysis
Table 74. GSK Recent Developments
Table 75. Teva Company Details
Table 76. Teva Business Overview
Table 77. Teva OTC Anti-Infective Drug Product and Services
Table 78. Teva OTC Anti-Infective Drug Revenue in OTC Anti-Infective Drug Business (2017-2022) & (US$ Million)
Table 79. Teva OTC Anti-Infective Drug SWOT Analysis
Table 80. Teva Recent Developments
Table 81. Johnson & Johnson Company Details
Table 82. Johnson & Johnson Business Overview
Table 83. Johnson & Johnson OTC Anti-Infective Drug Product and Services
Table 84. Johnson & Johnson OTC Anti-Infective Drug Revenue in OTC Anti-Infective Drug Business (2017-2022) & (US$ Million)
Table 85. Johnson & Johnson OTC Anti-Infective Drug SWOT Analysis
Table 86. Johnson & Johnson Recent Developments
Table 87. NOVARTIS Company Details
Table 88. NOVARTIS Business Overview
Table 89. NOVARTIS OTC Anti-Infective Drug Product and Services
Table 90. NOVARTIS OTC Anti-Infective Drug Revenue in OTC Anti-Infective Drug Business (2017-2022) & (US$ Million)
Table 91. NOVARTIS OTC Anti-Infective Drug SWOT Analysis
Table 92. NOVARTIS Recent Developments
Table 93. MYLAN Company Details
Table 94. MYLAN Business Overview
Table 95. MYLAN OTC Anti-Infective Drug Product and Services
Table 96. MYLAN OTC Anti-Infective Drug Revenue in OTC Anti-Infective Drug Business (2017-2022) & (US$ Million)
Table 97. MYLAN OTC Anti-Infective Drug SWOT Analysis
Table 98. MYLAN Recent Developments
Table 99. Sun Pharma Company Details
Table 100. Sun Pharma Business Overview
Table 101. Sun Pharma OTC Anti-Infective Drug Product and Services
Table 102. Sun Pharma OTC Anti-Infective Drug Revenue in OTC Anti-Infective Drug Business (2017-2022) & (US$ Million)
Table 103. Sun Pharma OTC Anti-Infective Drug SWOT Analysis
Table 104. Sun Pharma Recent Developments
Table 105. CR SANJIU Company Details
Table 106. CR SANJIU Business Overview
Table 107. CR SANJIU OTC Anti-Infective Drug Product and Services
Table 108. CR SANJIU OTC Anti-Infective Drug Revenue in OTC Anti-Infective Drug Business (2017-2022) & (US$ Million)
Table 109. CR SANJIU OTC Anti-Infective Drug SWOT Analysis
Table 110. CR SANJIU Recent Developments
Table 111. Cipla Company Details
Table 112. Cipla Business Overview
Table 113. Cipla OTC Anti-Infective Drug Product and Services
Table 114. Cipla OTC Anti-Infective Drug Revenue in OTC Anti-Infective Drug Business (2017-2022) & (US$ Million)
Table 115. Cipla OTC Anti-Infective Drug SWOT Analysis
Table 116. Cipla Recent Developments
Table 117. Lingrui Company Details
Table 118. Lingrui Business Overview
Table 119. Lingrui OTC Anti-Infective Drug Product and Services
Table 120. Lingrui OTC Anti-Infective Drug Revenue in OTC Anti-Infective Drug Business (2017-2022) & (US$ Million)
Table 121. Lingrui OTC Anti-Infective Drug SWOT Analysis
Table 122. Lingrui Recent Developments
Table 123. OTC Anti-Infective Drug Market Trends
Table 124. OTC Anti-Infective Drug Market Drivers
Table 125. OTC Anti-Infective Drug Market Challenges
Table 126. OTC Anti-Infective Drug Market Restraints
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global OTC Anti-Infective Drug Sales Market Share by Type: 2021 VS 2028
Figure 2. Antifungal Features
Figure 3. Antibacterial Features
Figure 4. Antiviral Features
Figure 5. Antiseptics Features
Figure 6. Other Features
Figure 7. Global OTC Anti-Infective Drug Sales Market Share by Application: 2021 VS 2028
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. OTC Anti-Infective Drug Report Years Considered
Figure 12. Global OTC Anti-Infective Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global OTC Anti-Infective Drug Market Size 2017-2028 (US$ Million)
Figure 14. Global OTC Anti-Infective Drug Market Size Market Share by Region: 2021 VS 2028
Figure 15. Global OTC Anti-Infective Drug Revenue Market Share by Region in 2017 VS 2022
Figure 16. Global Top 10 OTC Anti-Infective Drug Countries Ranking by Market Size (US$ Million) in 2021
Figure 17. Global OTC Anti-Infective Drug Market Share by Players in 2021
Figure 18. Global Top OTC Anti-Infective Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Drug as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by OTC Anti-Infective Drug Revenue in 2021
Figure 20. North America OTC Anti-Infective Drug Revenue Market Share by Company in 2021
Figure 21. North America OTC Anti-Infective Drug Revenue Market Share by Type (2017-2028)
Figure 22. North America OTC Anti-Infective Drug Revenue Market Share by Application (2017-2028)
Figure 23. North America OTC Anti-Infective Drug Revenue Share by Country (2017-2028)
Figure 24. United States OTC Anti-Infective Drug Revenue (2017-2028) & (US$ Million)
Figure 25. Canada OTC Anti-Infective Drug Revenue (2017-2028) & (US$ Million)
Figure 26. Europe OTC Anti-Infective Drug Revenue Market Share by Company in 2021
Figure 27. Europe OTC Anti-Infective Drug Revenue Market Share by Type (2017-2028)
Figure 28. Europe OTC Anti-Infective Drug Revenue Market Share by Application (2017-2028)
Figure 29. Europe OTC Anti-Infective Drug Revenue Share by Country (2017-2028)
Figure 30. Germany OTC Anti-Infective Drug Revenue (2017-2028) & (US$ Million)
Figure 31. France OTC Anti-Infective Drug Revenue (2017-2028) & (US$ Million)
Figure 32. U.K. OTC Anti-Infective Drug Revenue (2017-2028) & (US$ Million)
Figure 33. Italy OTC Anti-Infective Drug Revenue (2017-2028) & (US$ Million)
Figure 34. Russia OTC Anti-Infective Drug Revenue (2017-2028) & (US$ Million)
Figure 35. Asia Pacific OTC Anti-Infective Drug Revenue Market Share by Company in 2021
Figure 36. Asia Pacific OTC Anti-Infective Drug Revenue Market Share by Type (2017-2028)
Figure 37. Asia Pacific OTC Anti-Infective Drug Revenue Market Share by Application (2017-2028)
Figure 38. Asia Pacific OTC Anti-Infective Drug Revenue Share by Region (2017-2028)
Figure 39. China OTC Anti-Infective Drug Revenue (2017-2028) & (US$ Million)
Figure 40. Japan OTC Anti-Infective Drug Revenue (2017-2028) & (US$ Million)
Figure 41. South Korea OTC Anti-Infective Drug Revenue (2017-2028) & (US$ Million)
Figure 42. India OTC Anti-Infective Drug Revenue (2017-2028) & (US$ Million)
Figure 43. Australia OTC Anti-Infective Drug Revenue (2017-2028) & (US$ Million)
Figure 44. China Taiwan OTC Anti-Infective Drug Revenue (2017-2028) & (US$ Million)
Figure 45. Indonesia OTC Anti-Infective Drug Revenue (2017-2028) & (US$ Million)
Figure 46. Thailand OTC Anti-Infective Drug Revenue (2017-2028) & (US$ Million)
Figure 47. Malaysia OTC Anti-Infective Drug Revenue (2017-2028) & (US$ Million)
Figure 48. Latin America OTC Anti-Infective Drug Revenue Market Share by Company in 2021
Figure 49. Latin America OTC Anti-Infective Drug Revenue Market Share by Type (2017-2028)
Figure 50. Latin America OTC Anti-Infective Drug Revenue Market Share by Application (2017-2028)
Figure 51. Latin America OTC Anti-Infective Drug Revenue Share by Country (2017-2028)
Figure 52. Mexico OTC Anti-Infective Drug Revenue (2017-2028) & (US$ Million)
Figure 53. Brazil OTC Anti-Infective Drug Revenue (2017-2028) & (US$ Million)
Figure 54. Argentina OTC Anti-Infective Drug Revenue (2017-2028) & (US$ Million)
Figure 55. Middle East and Africa OTC Anti-Infective Drug Revenue Market Share by Company in 2021
Figure 56. Middle East and Africa OTC Anti-Infective Drug Revenue Market Share by Type (2017-2028)
Figure 57. Middle East and Africa OTC Anti-Infective Drug Revenue Market Share by Application (2017-2028)
Figure 58. Middle East and Africa OTC Anti-Infective Drug Revenue Share by Country (2017-2028)
Figure 59. Turkey OTC Anti-Infective Drug Revenue (2017-2028) & (US$ Million)
Figure 60. Saudi Arabia OTC Anti-Infective Drug Revenue (2017-2028) & (US$ Million)
Figure 61. UAE OTC Anti-Infective Drug Revenue (2017-2028) & (US$ Million)
Figure 62. Bayer Revenue Growth Rate in OTC Anti-Infective Drug Business (2017-2022)
Figure 63. GSK Revenue Growth Rate in OTC Anti-Infective Drug Business (2017-2022)
Figure 64. Teva Revenue Growth Rate in OTC Anti-Infective Drug Business (2017-2022)
Figure 65. Johnson & Johnson Revenue Growth Rate in OTC Anti-Infective Drug Business (2017-2022)
Figure 66. NOVARTIS Revenue Growth Rate in OTC Anti-Infective Drug Business (2017-2022)
Figure 67. MYLAN Revenue Growth Rate in OTC Anti-Infective Drug Business (2017-2022)
Figure 68. Sun Pharma Revenue Growth Rate in OTC Anti-Infective Drug Business (2017-2022)
Figure 69. CR SANJIU Revenue Growth Rate in OTC Anti-Infective Drug Business (2017-2022)
Figure 70. Cipla Revenue Growth Rate in OTC Anti-Infective Drug Business (2017-2022)
Figure 71. Lingrui Revenue Growth Rate in OTC Anti-Infective Drug Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs